Page 27 - Orange Book Cumulative Supplement 10 October 2012
P. 27
RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012 1-17
SUSPENSION; INHALATION
BUDESONIDE
AN TEVA PHARMS 0.25MG/2ML A077519 001 Nov 18, 2008 Sep CAHN
AN 0.5MG/2ML A077519 002 Nov 18, 2008 Sep CAHN
AN WATSON LABS INC 0.25MG/2ML A078404 001 Jul 31, 2012 Jul NEWA
AN 0.5MG/2ML A078404 002 Jul 31, 2012 Jul NEWA
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
AEROSOL, METERED; INHALATION
SYMBICORT
+ ASTRAZENECA 0.08MG/INH;0.0045MG/INH N021929 001 Jul 21, 2006 Jan CDFR
+ 0.16MG/INH;0.0045MG/INH N021929 002 Jul 21, 2006 Jan CDFR
BUMETANIDE
INJECTABLE; INJECTION
BUMETANIDE
>D> AP BAXTER HLTHCARE 0.25MG/ML A079196 001 Apr 30, 2008 Oct CAHN
>A> AP HIKMA MAPLE 0.25MG/ML A079196 001 Apr 30, 2008 Oct CAHN
BUPIVACAINE
INJECTABLE, LIPOSOMAL; INJECTION
EXPAREL
@ PACIRA PHARMS INC 133MG/10ML (13.3MG/ML) N022496 001 Oct 28, 2011 Jul DISC
BUPRENORPHINE HYDROCHLORIDE
TABLET; SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE
AB + ROXANE EQ 8MG BASE A078633 002 Oct 08, 2009 Aug CRLD
SUBUTEX
@ RECKITT BENCKISER EQ 2MG BASE N020732 002 Oct 08, 2002 Aug DISC
@ EQ 8MG BASE N020732 003 Oct 08, 2002 Aug DISC
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
FILM; SUBLINGUAL
SUBOXONE
RECKITT BENCKISER EQ 2MG BASE;EQ 0.5MG BASE N022410 001 Aug 30, 2010 Apr CAIN
EQ 4MG BASE;EQ 1MG BASE N022410 003 Aug 10, 2012 Aug NEWA
+ EQ 8MG BASE;EQ 2MG BASE N022410 002 Aug 30, 2010 Apr CAIN
EQ 12MG BASE;EQ 3MG BASE N022410 004 Aug 10, 2012 Aug NEWA
TABLET; SUBLINGUAL
SUBOXONE
RECKITT BENCKISER EQ 2MG BASE;EQ 0.5MG BASE N020733 001 Oct 08, 2002 Apr CPOT
+ EQ 8MG BASE;EQ 2MG BASE N020733 002 Oct 08, 2002 Apr CPOT
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
BUPROPION HYDROCHLORIDE
BX IMPAX LABS 300MG A077415 002 Dec 15, 2006 Sep CTEC
AB1 WOCKHARDT LTD 100MG A201331 001 Aug 30, 2012 Aug NEWA
AB1 150MG A201331 002 Aug 30, 2012 Aug NEWA
AB1 200MG A201331 003 Aug 30, 2012 Aug NEWA
FORFIVO XL
+ EDGEMONT PHARMS LLC 450MG N022497 001 Nov 10, 2011 Mar CAHN
WELLBUTRIN SR
AB1 GLAXOSMITHKLINE 150MG N020358 003 Oct 04, 1996 Sep CRLD
AB1 + 200MG N020358 004 Jun 14, 2002 Sep CRLD